Application and mechanism of biomarkers in predicting postoperative pain and opioid consumption in cancer patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046447

Enrollment

Unknown

Registered

2021-05-15

Start date

2021-06-01

Completion date

Unknown

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain

Interventions

Two groups:none

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years, ASA classification I to III; 2. Patients who are pathologically diagnosed as malignant tumors who are planning to undergo radical cancer surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with tumor recurrence; 2. Merge with other primary malignant tumors; 3. Patients who have been treated with psychotropic drugs and analgesics for a long time; 4. Patients with schizophrenia or epilepsy before surgery; 5. Patients with a history of chronic pain; 6. Severe liver and kidney function abnormalities.

Design outcomes

Primary

Measure	Time frame
Opioid consumption;Metabolomics;Proteomics;	—

Secondary

Measure	Time frame
Pain score;	—

Countries

China

Contacts

Public ContactTan Hongyu

Beijing Cancer Hospital

maggitan@163.com+86 18611698336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026